Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Investment Summary

Market Valuation
Undervalued
Consensus
Skip
Best For

How This Company Makes Money

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Business Quality Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

MaxDividends Quality Score

Business Quality Score
Dividend Score

Sales Growth PTGX

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin PTGX

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income PTGX

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM PTGX

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio PTGX

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Protagonist Therapeutics Inc PTGX

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself PTGX

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE 28.90
Enterprise Value Revenue 111.36
Price Sales TTM 127.72
Enterprise Value EBITDA 244.64
Price Book MRQ 13.40

Bottom Line

Protagonist Therapeutics Inc

PTGX
Current price
146.18 USD +1.17 USD (+0.81%)
Last closed 135.81 USD
ISIN US74366E1029
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 9 459 056 640 USD
Yield for 12 month +171.96 %
1Y
3Y
5Y
10Y
15Y
PTGX
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+46 016 000 USD

Last Year

+434 433 000 USD

Current Quarter

+213 475 000 USD

Last Quarter

+56 368 000 USD

Current Year

+44 791 000 USD

Last Year

+434 433 000 USD

Current Quarter

Last Quarter

+55 961 000 USD
EBITDA -141 016 992 USD
Operating Margin TTM -6.47 %
Price to Earnings
Return On Assets TTM -12.37 %
PEG Ratio
Return On Equity TTM -17.06 %
Wall Street Target Price 150.54 USD
Revenue TTM 74 063 000 USD
Book Value 10.21 USD
Revenue Per Share TTM 1.16 USD
Dividend Share
Quarterly Revenue Growth YOY 99.00 %
Dividend Yield
Gross Profit TTM 74 063 000 USD
Earnings Per Share -1.93 USD
Diluted EPS TTM -1.93 USD
Most Recent Quarter II 2026
Quarterly Earnings Growth YOY 351.30 %
Profit Margin -154.88 %
Price to Free Cash Flow TTM 73.17

Technical Indicators PTGX

For 52 Weeks

50.58 USD 148.00 USD
50 Day MA 121.62 USD
Shares Short Prior Month 7 691 347
200 Day MA 98.18 USD
Short Ratio 8.67
Shares Short 8 292 656
Short Percent 15.00 %